Career goals-
My goal is to
become an independent investigator of infectious viral diseases. I am
interested in using interdisciplinary approaches to develop novel strategies
and therapeutics for preventing and controlling viral transmission that will be
applied clinically.
Thesis proposal-
Human
cytomegalovirus (HCMV) is the leading cause of virus-induced birth defects and
is a major opportunistic pathogen for the immunocompromised1,2. The clinical recognition of primary
HCMV infection is complicated by the fact that acute replication is typically
asymptomatic in immunocompetent individuals. A robust immune response limits viral
replication to sites of persistence in the salivary glands, mammary glands, and
kidneys. At these sites, HCMV establishes a long-lived, persistent infection
that promotes transmission via saliva, breast milk, and urine to naive
individuals. A major challenge to controlling HCMV infection is to define the
mechanisms that control viral persistence and transmission. Our lab studies a
large, stable non-coding RNA encoded by HCMV that has been linked to viral
persistence3. This intron is conserved across all species of
cytomegaloviruses, suggesting it may play a significant role in pathogenesis4. We have used Murine Cytomegalovirus
(MCMV) as a model system to study the function of the intron in viral
replication in vitro and in vivo. MCMV mutants lacking the stable
intron replicate normally during the acute phase of infection, yet fail to
establish persistent replication in the salivary gland of the mouse4. Therefore, we hypothesize that
the MCMV intron locus is a key determinant for viral persistence. The objective
of my thesis work is to investigate transcriptional regulation of the MCMV
intron locus in vitro and in vivo to understand the molecular
mechanisms that control intron locus temporal expression and ultimately
function.
Aim 1: Fully define
the MCMV intron locus. In
addition to the 7.2-kb intron, multiple RNAs have been detected from the MCMV
intron locus. To determine whether all RNAs identified are derived from a
common primary transcript, I am currently resolving the exon and intron
boundaries of the precursor RNA using 5’RACE, RNase protection and northern
blot analysis.
Aim 2: Identify
regulatory elements that drive transcription of the MCMV 7.2-kb intron locus.
The DNA sequence proximal to the intron locus lacks identifiable
transcriptional control elements such as a TATA box. To investigate the promoter elements that
temporally regulate expression of the intron locus over the course of
infection, I am using a luciferase reporter system to identify regions that
confer transcriptional control in vitro.
Aim 3: Identify
viral factors that regulate MCMV intron locus transcription. The intron locus relies on viral
replication to occur at late times during infection for expression. To
demonstrate that the intron locus is highly regulated by viral transcriptional
repressors and activators over the course of infection, I will identify viral
factors that bind to DNA regions upstream and/or downstream of the
transcriptional start site by employing EMSA, ChIP, and reporter assays.
1. Landolfo,
S. et al. The human cytomegalovirus. Pharmacology
& therapeutics 98,
269-97(2003).
2. CDC
- CMV: Congenital CMV Infection Trends and Statistics. at
<http://www.cdc.gov/cmv/trends-stats.html>
3. Kulesza,
C.A. & Shenk, T. Human cytomegalovirus 5-kilobase immediate-early RNA is a
stable intron. Journal of virology 78, 13182-9(2004).
4. Kulesza,
C.A. & Shenk, T. Murine cytomegalovirus encodes a stable intron that
facilitates persistent replication in the mouse. Proceedings of the National Academy of Sciences of the United States of
America 103, 18302-7(2006).
e-mail Toni